Accordingly, the experimental loss of TTLL3 in a mouse model of tumorigenesis resulted in the development of cancer, thus validating its downregulation in colon cancer and suggesting a cancer-suppressing role for tubulin glycylation [110]. The gene discussed is TTLL3; the disease is colonic neoplasm.